Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$29.51 - $46.26 $611,299 - $958,275
-20,715 Closed
0 $0
Q2 2024

Aug 14, 2024

SELL
$22.21 - $34.48 $326,553 - $506,959
-14,703 Reduced 41.51%
20,715 $673,000
Q1 2024

May 13, 2024

SELL
$21.1 - $27.46 $291,348 - $379,167
-13,808 Reduced 28.05%
35,418 $892,000
Q4 2023

Oct 21, 2024

BUY
$24.82 - $32.88 $420,103 - $556,526
16,926 Added 52.4%
49,226 $1.6 Million
Q4 2023

Feb 07, 2024

BUY
$24.82 - $32.88 $1.22 Million - $1.62 Million
49,226 New
49,226 $1.6 Million
Q2 2023

Oct 21, 2024

BUY
$21.44 - $25.15 $248,382 - $291,362
11,585 Added 55.93%
32,300 $718,000
Q2 2023

Aug 07, 2023

BUY
$21.44 - $25.15 $692,512 - $812,345
32,300 New
32,300 $718,000
Q4 2022

Feb 13, 2023

BUY
$19.95 - $29.96 $189,305 - $284,290
9,489 Added 13.2%
81,389 $1.65 Million
Q3 2022

Nov 07, 2022

SELL
$24.7 - $29.12 $513,908 - $605,870
-20,806 Reduced 22.44%
71,900 $1.84 Million
Q2 2022

Aug 09, 2022

BUY
$17.33 - $25.3 $857,731 - $1.25 Million
49,494 Added 114.54%
92,706 $2.21 Million
Q1 2022

May 12, 2022

BUY
$16.53 - $25.21 $714,294 - $1.09 Million
43,212 New
43,212 $973,000
Q4 2021

Feb 10, 2022

SELL
$17.1 - $23.34 $291,195 - $397,456
-17,029 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$19.68 - $22.53 $335,130 - $383,663
17,029 New
17,029 $335,000
Q1 2021

May 17, 2021

SELL
$23.49 - $30.56 $675,384 - $878,661
-28,752 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$16.78 - $27.3 $482,458 - $784,929
28,752 New
28,752 $752,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.17B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.